Product
Actos
Aliases
Actos® Tablets 45 mg
Name
Actos
INN Name
pioglitazone hydrochloride
FDA Approved
Yes
3 clinical trials
3 organizations
5 indications
1 document
Indication
PrediabetesIndication
WeightIndication
BodyIndication
Cardiovascular DiseasesIndication
HealthyClinical trial
Pioneering and Affordable Strategies to Prevent Progression of Prediabetes, Obesity and CV Risk in HispanicsStatus: Recruiting, Estimated PCD: 2027-07-01
Clinical trial
Single-Dose Food In Vivo Bioequivalence Study of Pioglitazone HCl Tablets (45 mg; Mylan) to Actos® Tablets (45 mg; Takeda) in Healthy VolunteersStatus: Completed, Estimated PCD: 2003-03-01
Clinical trial
Single-Dose Fasting In Vivo Bioequivalence Study of Pioglitazone HCl Tablets (45 mg; Mylan) and Actos® Tablets (45 mg; Takeda) in Healthy VolunteersStatus: Completed, Estimated PCD: 2003-03-01
Document
DailyMed Label: ActosOrganization
Rebel Distributors Corp.Organization
Dispensing Solutions, Inc.Organization
Takeda Pharmaceuticals America, Inc.